ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

0A4J Astrazeneca Plc

0.00
0.00 (0.00%)
- - 終了
15分遅延
名称 銘柄コード 市場 種別
Astrazeneca Plc 0A4J ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
0.00 0.00% -
始値 安値 高値 終値 前日終値
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/1/0300:00UKREGAstraZeneca PLC Total Voting Rights
2023/12/2716:00UKREGAstraZeneca PLC AstraZeneca acquires Gracell
2023/12/2216:00UKREGAstraZeneca PLC Wainua (eplontersen) granted first US FDA..
2023/12/1500:00UKREGAstraZeneca PLC Director/PDMR Shareholding
2023/12/1216:05UKREGAstraZeneca PLC AstraZeneca to acquire Icosavax
2023/12/0200:05UKREGAstraZeneca PLC Block listing Interim Review
2023/12/0200:00UKREGAstraZeneca PLC Total Voting Rights
2023/12/0116:00UKREGAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence..
2023/11/2400:00UKREGAstraZeneca PLC Director/PDMR Shareholding
2023/11/1716:00UKREGAstraZeneca PLC Truqap approved in US for HR+ breast cancer
2023/11/1416:05UKREGAstraZeneca PLC Update on PACIFIC-2 Phase III trial for..
2023/11/1000:00UKREGAstraZeneca PLC Director Declaration
2023/11/0916:10UKREGAstraZeneca PLC Imfinzi combination improves PFS in liver..
2023/11/0916:05UKREGAstraZeneca PLC Agreement with Eccogene for clinical stage..
2023/11/0916:00UKREGAstraZeneca PLC 9M and Q3 2023 results
2023/11/0200:00UKREGAstraZeneca PLC Total Voting Rights
2023/11/0116:00UKREGAstraZeneca PLC AstraZeneca cell & gene therapy deal w/..
2023/10/0315:00UKREGAstraZeneca PLC AstraZeneca settles Nexium liability..
2023/10/0223:00UKREGAstraZeneca PLC Total Voting Rights
2023/9/2215:00UKREGAstraZeneca PLC Dato-DXd improved PFS in breast cancer
2023/9/2015:00UKREGAstraZeneca PLC Alexion completes Pfizer gene therapy..
2023/9/1523:00UKREGAstraZeneca PLC Enhertu recommended in EU for HER2-mutant..
2023/9/1200:00UKREGAstraZeneca PLC Fasenra Phase III EGPA trial met primary..
2023/9/0615:00UKREGAstraZeneca PLC Update on US review of Ultomiris for NMOSD
2023/9/0123:00UKREGAstraZeneca PLC Total Voting Rights
2023/8/0123:00UKREGAstraZeneca PLC Total Voting Rights
2023/7/2815:05UKREGAstraZeneca PLC Alexion enters gene therapy agreement with..
2023/7/2815:00UKREGAstraZeneca PLC Half-year Report
2023/7/1802:10UKREGAstraZeneca PLC Beyfortus approved in US for infant RSV..
2023/7/0323:00UKREGAstraZeneca PLC Total Voting Rights
2023/7/0315:00UKREGAstraZeneca PLC Dato-DXd significantly improved PFS in lung..
2023/6/0915:05UKREGAstraZeneca PLC nirsevimab recommended for infant RSV..
2023/6/0915:00UKREGAstraZeneca PLC AstraZeneca agreement with Quell..
2023/6/0301:00UKREGAstraZeneca PLC Imfinzi improved pCR in gastric and GEJ..
2023/6/0123:05UKREGAstraZeneca PLC Block listing Interim Review
2023/6/0123:00UKREGAstraZeneca PLC Total Voting Rights
2023/6/0115:00UKREGAstraZeneca PLC Lynparza approved in US for BRCAm prostate..
2023/5/2615:00UKREGAstraZeneca PLC Imfinzi + Lynparza prolonged PFS in..
2023/5/2215:05UKREGAstraZeneca PLC Directorate Change
2023/5/1715:00UKREGAstraZeneca PLC Tagrisso plus chemo improved PFS in lung..
2023/5/0919:00UKREGAstraZeneca PLC Director/PDMR Shareholding
2023/5/0915:00UKREGAstraZeneca PLC Farxiga extended in the US for heart failure
2023/5/0223:00UKREGAstraZeneca PLC Total Voting Rights
2023/5/0218:00UKREGAstraZeneca PLC Director/PDMR Shareholding
2023/5/0215:00UKREGAstraZeneca PLC ODAC vote on Lynparza combo in prostate..

最近閲覧した銘柄

Delayed Upgrade Clock